Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Fish and Richardson
Johnson and Johnson
Boehringer Ingelheim
Argus Health
Express Scripts
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,977,099

« Back to Dashboard

Summary for Patent: 5,977,099

Title: Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
Abstract:The invention relates to a pharmaceutical composition comprising mirtazapine, a selective serotonin reuptake inhibitor (SSRI) and pharmaceutically acceptable auxiliaries. In particular the SSRI is selected from fluoxetine, fluvoxamine, citalopram, cericlamine, femoxetine, sertraline, paroxetine, ifoxetine, cyanodothiepin and litoxetine. The composition which can be used to treat depressant patients has less side effects than treatment of the patients with mirtazapine or the SSRI alone.
Inventor(s): Nickolson; Victor Johannes (Hermelijnendreef, NL)
Assignee: Akzo Nobel, N.V. (Arnhem, NL)
Application Number:08/876,346
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,977,099

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
96201703Jun 19, 1996

International Patent Family for Patent: 5,977,099

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway972816► Subscribe
Mexico9704579► Subscribe
Japan4925074► Subscribe
Japan2009137970► Subscribe
JapanH1067663► Subscribe
Israel121076► Subscribe
Indonesia17051► Subscribe
Hungary225534► Subscribe
Hungary9701068► Subscribe
Spain2172744► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Chinese Patent Office
Johnson and Johnson
Daiichi Sankyo
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: